MOVING SCIENCE FORWARD
MultiPark is a strategic research area funded by the Swedish Government. Building on the strong tradition of cutting-edge research on Parkinson's and Alzheimer's diseases at Lund University, our vision is to create new and innovative strategies for improved and novel treatments, disease modifications and eventually cures for neurodegenerative diseases, in order to improve the quality of life for people living and ageing with these disorders.
MultiPark board member Maiken Nedergaard is awarded the Nordic Fernström Prize.
Diagnosing Alzheimer's disease can be difficult, as several other conditions can cause similar symptoms. Now a new brain imaging method can show the spread of specific tau protein depositions, which are unique to cases with Alzheimer's. ‟The method works very well. I believe it will be applied clinically all over the world in only a few years”, says Oskar Hansson. Hansson is a professor of clinical memory research at Lund University in Sweden who has led a major international study on the new method.
Editorial by Director Gunnar Gouras - The MultiPark management hopes that you had a wonderful summer and that you are ready for another productive academic year of advances against Parkinson’s disease, Alzheimer’s disease, and related neurodegenerative diseases. A major change from before the summer is that the Linnaeus environment Bagadilico ended during the summer. Over the past few years the MultiPark management, steering group and board have worked to integrate infrastructures funded by Bagadilico into MultiPark. This has been largely successful, although more work remains.
One of the world’s largest pharmaceutical companies, Novo Nordisk, is starting a new stem cell program for the treatment of Parkinson’s disease in close collaboration with Lund University.
Editorial by Director Gunnar Gouras - The MultiPark management looks forward to another productive year and hopes all in our environment have had nice holidays. Looking back at our annual retreat on December 1 we again thank our invited speakers, Thomas Nyström, professor at the University of Gothenburg and a leading expert on the biology of aging, and Iben Lundegaard, our new colleague and Wallenberg Molecular Medicine scholar in neuroscience.